NO20081230L - Inhibitorer av enzymet HIV integrase - Google Patents

Inhibitorer av enzymet HIV integrase

Info

Publication number
NO20081230L
NO20081230L NO20081230A NO20081230A NO20081230L NO 20081230 L NO20081230 L NO 20081230L NO 20081230 A NO20081230 A NO 20081230A NO 20081230 A NO20081230 A NO 20081230A NO 20081230 L NO20081230 L NO 20081230L
Authority
NO
Norway
Prior art keywords
inhibitors
hiv integrase
enzyme hiv
enzyme
integrase
Prior art date
Application number
NO20081230A
Other languages
English (en)
Inventor
Klaus Ruprecht Dress
Ted William Johnson
Michael Bruno Plewe
Steven Paul Tanis
Huichun Zhu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37684843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081230(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20081230L publication Critical patent/NO20081230L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det beskrives forbindelser av formel (I), og farmasøytisk akseptable salter og solvater derav, fremstilling av disse, og deres anvendelse om modulatorer eller inhibitorer av enzymet HIV(human immunsviktvirus)-integrase.
NO20081230A 2005-10-07 2008-03-07 Inhibitorer av enzymet HIV integrase NO20081230L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US72448405P 2005-10-07 2005-10-07
US73070105P 2005-10-26 2005-10-26
US76160506P 2006-01-24 2006-01-24
US82395406P 2006-08-30 2006-08-30
US82637906P 2006-09-20 2006-09-20
PCT/IB2006/002735 WO2007042883A1 (en) 2005-10-07 2006-09-25 Inhibitors of the hiv integrase enzyme

Publications (1)

Publication Number Publication Date
NO20081230L true NO20081230L (no) 2008-04-08

Family

ID=37684843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081230A NO20081230L (no) 2005-10-07 2008-03-07 Inhibitorer av enzymet HIV integrase

Country Status (21)

Country Link
US (1) US20070099915A1 (no)
EP (1) EP1934220A1 (no)
JP (1) JP2009511463A (no)
KR (1) KR20080042171A (no)
AP (1) AP2008004400A0 (no)
AR (1) AR061398A1 (no)
AU (1) AU2006300926A1 (no)
BR (1) BRPI0616657A2 (no)
CA (1) CA2623506A1 (no)
CR (1) CR9859A (no)
EA (1) EA200800758A1 (no)
IL (1) IL189939A0 (no)
MA (1) MA29855B1 (no)
NL (1) NL2000255A1 (no)
NO (1) NO20081230L (no)
PE (1) PE20070494A1 (no)
RS (1) RS20080141A (no)
SV (1) SV2009002864A (no)
TW (1) TW200800219A (no)
UY (1) UY29843A1 (no)
WO (1) WO2007042883A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2563761C (en) * 2004-04-26 2009-12-29 Pfizer Inc. Inhibitors of the hiv integrase enzyme
AU2008350907A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN102532021B (zh) * 2012-01-31 2013-10-16 天津大学 2-烷氧基-3,4-二取代异喹啉-1(2h)-酮类衍生物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
EP0627436A1 (en) * 1991-08-08 1994-12-07 TSUMURA & CO. Carcinostatic compound and production thereof
EP0713877A1 (en) * 1993-07-19 1996-05-29 LUO, Xuande Qinghaosu derivatives against aids
US6057297A (en) * 1996-08-06 2000-05-02 Polifarma S.P.A. Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
US6403347B1 (en) * 1998-02-03 2002-06-11 Merck & Co., Inc. HIV integrase inhibitors
AU8009900A (en) * 1999-10-13 2001-04-23 Merck & Co., Inc. Hiv integrase inhibitors
CN1239472C (zh) * 2000-06-16 2006-02-01 布里斯托尔-迈尔斯斯奎布公司 Hiv整合酶抑制剂
PA8586801A1 (es) * 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
BRPI0407052A (pt) * 2003-01-27 2006-01-17 Pfizer Inibidores da hiv-integrase, composições farmacêuticas, e métodos para sua utilização
CA2563761C (en) * 2004-04-26 2009-12-29 Pfizer Inc. Inhibitors of the hiv integrase enzyme
MX2007002731A (es) * 2004-09-07 2007-04-23 Pfizer Inhibidores de la enzima integrasa del hiv.

Also Published As

Publication number Publication date
SV2009002864A (es) 2009-02-19
PE20070494A1 (es) 2007-06-13
AP2008004400A0 (en) 2008-04-30
AU2006300926A1 (en) 2007-04-19
AR061398A1 (es) 2008-08-27
MA29855B1 (fr) 2008-10-03
RS20080141A (en) 2009-07-15
CR9859A (es) 2008-06-20
EP1934220A1 (en) 2008-06-25
US20070099915A1 (en) 2007-05-03
UY29843A1 (es) 2007-05-31
KR20080042171A (ko) 2008-05-14
TW200800219A (en) 2008-01-01
IL189939A0 (en) 2008-08-07
BRPI0616657A2 (pt) 2011-06-28
EA200800758A1 (ru) 2008-08-29
NL2000255A1 (nl) 2007-04-11
JP2009511463A (ja) 2009-03-19
CA2623506A1 (en) 2007-04-19
WO2007042883A1 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
WO2005115398A3 (en) Hiv integrase inhibitors
NO20063925L (no) Indazolderivater som inhibitorer av hormonsensitiv lipase
NO20081844L (no) Terapeutiske forbindelser
BRPI0510319A (pt) inibidores da enzima integrase de hiv
NO20055135L (no) Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer
WO2009146555A8 (en) Hiv integrase inhibitors from pyridoxine
NO20081878L (no) Diacylindazolderivater som lipase- og fosfolipaseinhibitorer
NO20044534L (no) Substituerte fenylacetamider og deres anvendelse som glukokinaseaktivatorer
NO20066055L (no) Pyridinderivater
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
NO20063958L (no) HIV integrase inhibitorer
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
WO2007013047A3 (en) Water-dispersible anti-retroviral pharmaceutical compositions
NO20075992L (no) Forbindelser som modulerer C-Kit og C-FMS aktivitet og anvendelser derav
TN2010000212A1 (en) Inhibitors of human immunodeficiency virus replication
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
DK1569929T3 (da) Forbindelser og fremgangsmåder til behandling eller forebyggelse af flavi-virusinfektioner
NO20090346L (no) Pyrazolderivater som inhibitorer av cytokrom P450
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
NO20084049L (no) Forbindelser med forsterket ampa receptor og anvendelse derav i medisin
NO20063576L (no) 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes
WO2008118849A3 (en) Hiv-1 protease inhibitors
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
NL1024676A1 (nl) HIV integrase-remmers, farmaceutische preparaten en methoden voor het gebruik daarvan.
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application